MedPath

PREVYMIS

PREVYMIS

Approved
DIN Number

02469383

Drug Class

Human

Market Date

Dec 20, 2017

Company
HC

Merck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02469383
AIG Number0159630003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AX OTHER ANTIVIRALS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

LETERMOVIRActive
Strength: 480 MG
Monograph: LETERMOVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.